Literature DB >> 15639126

Taking steps towards reducing osteoporosis in Duchenne muscular dystrophy.

Laura K Bachrach1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15639126     DOI： 10.1016/j.nmd.2004.10.011

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  10 in total

1.  Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment.

Authors:  M L Bianchi; L Morandi; E Andreucci; S Vai; J Frasunkiewicz; R Cottafava
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.

Authors:  D M Escolar; L P Hache; P R Clemens; A Cnaan; C M McDonald; V Viswanathan; A J Kornberg; T E Bertorini; Y Nevo; T Lotze; A Pestronk; M M Ryan; E Monasterio; J W Day; A Zimmerman; A Arrieta; E Henricson; J Mayhew; J Florence; F Hu; A M Connolly
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

3.  Insights into bone health in Duchenne muscular dystrophy.

Authors:  Victor H Morgenroth; Lauren P Hache; Paula R Clemens
Journal:  Bonekey Rep       Date:  2012-02-01

Review 4.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Authors:  Jennifer M Bell; Michael D Shields; Janet Watters; Alistair Hamilton; Timothy Beringer; Mark Elliott; Rosaline Quinlivan; Sandya Tirupathi; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

Review 5.  Bone health and associated metabolic complications in neuromuscular diseases.

Authors:  Nanette C Joyce; Lauren P Hache; Paula R Clemens
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-10-17       Impact factor: 1.784

Review 6.  Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives.

Authors:  Maria de los Angeles Beytía; Julia Vry; Janbernd Kirschner
Journal:  Acta Myol       Date:  2012-05

Review 7.  [Current care strategies for Duchenne muscular dystrophy].

Authors:  A Fujak; G Haaker; J Funk
Journal:  Orthopade       Date:  2014-07       Impact factor: 1.004

Review 8.  Optimizing Bone Health in Duchenne Muscular Dystrophy.

Authors:  Jason L Buckner; Sasigarn A Bowden; John D Mahan
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

Review 9.  Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture.

Authors:  Keryn G Woodman; Chantal A Coles; Shireen R Lamandé; Jason D White
Journal:  Nutrients       Date:  2016-11-09       Impact factor: 5.717

Review 10.  Isolation, characterization, and molecular regulation of muscle stem cells.

Authors:  So-Ichiro Fukada; Yuran Ma; Takuji Ohtani; Yoko Watanabe; Satoshi Murakami; Masahiko Yamaguchi
Journal:  Front Physiol       Date:  2013-11-12       Impact factor: 4.566
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.